The Claim
In bovine hepatocytes, treatment with 3.6–7.2 mM sodium acetate increases phosphorylation and decreases activity of acetyl-CoA carboxylase (ACC1), a key enzyme in fatty acid synthesis, and this effect is blocked by AMPKα inhibition, suggesting that acetate suppresses de novo lipogenesis through AMPK-mediated inactivation of ACC1 in these cells.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In cow liver cells, a chemical called acetate seems to turn off a key fat-making enzyme by flipping a molecular switch, and this only happens when another switch (called AMPK) is working.
See the scientific wording
In bovine hepatocytes, treatment with 3.6–7.2 mM sodium acetate is associated with increased phosphorylation and reduced activity of acetyl-CoA carboxylase (ACC1), a key enzyme in fatty acid synthesis, with the effect being blocked by AMPKα inhibition, indicating that acetate may suppress de novo lipogenesis through AMPK-mediated inactivation of ACC1 in these cells.
What the research says
1 studyThe study shows that acetate turns on a cellular switch (AMPK) in cow liver cells that slows down fat production by turning off a key fat-making enzyme, and this effect goes away if you block the switch—just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.